CARDIFF ONCOLOGY, INC. (CRDF) Total assets 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) total assets at each fiscal year-end, per SEC filings.
$61.9MFY2025 · since FY2016: $44.0M → $61.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $61.9M | -36.3% |
| FY2024 | $97.2M | +19.1% |
| FY2023 | $81.6M | -29.7% |
| FY2022 | $116.2M | -22.3% |
| FY2021 | $149.5M | +11.0% |
| FY2020 | $134.7M | +929.5% |
| FY2019 | $13.1M | -7.7% |
| FY2018 | $14.2M | +15.4% |
| FY2017 | $12.3M | -72.0% |
| FY2016 | $44.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross profitCRDF Gross marginCRDF Operating incomeCRDF Operating marginCRDF Operating cash flowCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →